Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population

Table 3 Association of microalbuminuria with the metabolic syndrome components as dichotomized variables

The metabolic syndrome component	Number (Prevalence, %)	Unadjusted		Adjusted Model 1^a		Adjusted Model 2^b
		Odds ratio (95% CI)	P value	Odds ratio (95% CI)	P value	Odds ratio (95% CI)	P value
Central obesity	422 (39.1)	3.38 (1.80-6.34)	0.0001	2.52 (1.09-5.83)	0.03	2.24 (0.96-5.24)	0.06
Elevated blood pressure	522 (48.4)	3.16 (1.62-6.18)	0.0007	2.85 (1.22-6.67)	0.02	2.16 (1.01-4.63)	0.04
Elevated fasting plasma glucose	126 (11.7)	3.53 (1.83-6.81)	0.0002	3.03 (1.55-5.94)	0.001	2.57 (1.29-5.11)	0.007
Elevated serum triglycerides	356 (33.0)	2.10 (1.16-3.80)	0.01	1.75 (0.94-3.26)	0.08	1.30 (0.67-2.55)	0.44
Reduced serum HDL cholesterol	87 (8.1)	2.14 (0.93-4.94)	0.07	1.71 (0.71-4.08)	0.23	1.29 (0.51-3.25)	0.59

CI, confidence interval; HDL, high density lipoprotein.
The metabolic syndrome component was defined according to the Adult Treatment Panel III criteria (ATP III) criteria [6]. For further information, see methods.
^aAdjusted for sex, age, body mass index, current smoking, current alcoholic intake and use of antihypertensive drugs (except for elevated blood pressure).
^bAdditionally adjusted for the other components of metabolic syndrome.

ISSN: 1758-5996